IPO registrations (S-1, F-1) · Registrants
HeartSciences Inc.
- SEC CIK
- 1468492 · filings on EDGAR ↗
- Name on the registration
- Heart Test Laboratories, Inc.
- Former names
- Heart Test Laboratories, Inc. (2009–2024)
- Registration
- Form S-1, first filed 2022-05-17, last 2024-09-27; 5 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2022-06-17; declared effective 2022-06-14; withdrawal requested 2024-12-17
- Industry (SIC)
- Finance Services 6199
- Incorporated in
- TX
- Business address
- 550 RESERVE ST, SUITE 360, Southlake, TX 76092
- EIN
- 26-1344466
- Ticker
- HSCS, HSCSW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- HeartSciences Inc. on the corporate pages
Offering terms
- Proposed price range
- $4.50–$5.50 per share (S-1/A filed 2022-06-13)
- Final price
- $4.25 per share, below the range (424B4 filed 2022-06-17, an initial public offering)
- Shares sold
- 1,500,000
- Gross proceeds
- $6,375,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol HSCS
- Lead underwriters
- The Benchmark Company
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: HEARTSCIENCES INC. Fuzzy (name and state)
- Form 5500 plan sponsor: HEARTSCIENCES INC. EXACT (EIN (EXACT))
- Form D issuer: Heart Test Laboratories, Inc. EXACT (CIK (EXACT))
- SEC filer: HeartSciences Inc. EXACT (CIK (EXACT))
Filings 19
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-05-17 | S-1 | S-1 (registration) | Heart Test Laboratories, Inc. | 0001193125-22-153172 ↗ |
| 2022-06-06 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001193125-22-167822 ↗ |
| 2022-06-10 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001193125-22-171788 ↗ |
| 2022-06-13 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001193125-22-172784 ↗ |
| 2022-06-14 | EFFECT | EFFECT (declared effective) | Heart Test Laboratories, Inc. | 9999999995-22-001783 ↗ |
| 2022-06-17 | 424B4 | 424B4 (final prospectus) | Heart Test Laboratories, Inc. | 0001193125-22-176461 ↗ |
| 2022-09-12 | S-1 | S-1 (registration) | Heart Test Laboratories, Inc. | 0001193125-22-242951 ↗ |
| 2022-10-06 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001193125-22-258843 ↗ |
| 2022-10-07 | EFFECT | EFFECT (declared effective) | Heart Test Laboratories, Inc. | 9999999995-22-002990 ↗ |
| 2023-03-29 | S-1 | S-1 (registration) | Heart Test Laboratories, Inc. | 0001193125-23-083866 ↗ |
| 2023-04-10 | EFFECT | EFFECT (declared effective) | Heart Test Laboratories, Inc. | 9999999995-23-000880 ↗ |
| 2023-06-07 | S-1 | S-1 (registration) | Heart Test Laboratories, Inc. | 0001193125-23-162663 ↗ |
| 2023-09-28 | EFFECT | EFFECT (declared effective) | Heart Test Laboratories, Inc. | 9999999995-23-002824 ↗ |
| 2023-10-16 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001013762-23-003918 ↗ |
| 2024-03-05 | S-1 | S-1 (registration) | Heart Test Laboratories, Inc. | 0001213900-24-020156 ↗ |
| 2024-03-13 | EFFECT | EFFECT (declared effective) | Heart Test Laboratories, Inc. | 9999999995-24-000657 ↗ |
| 2024-09-27 | S-1/A | S-1/A (amendment) | Heart Test Laboratories, Inc. | 0001213900-24-082775 ↗ |
| 2024-12-17 | RW | RW (withdrawal request) | HeartSciences Inc. | 0001213900-24-109831 ↗ |
| 2024-12-19 | RW | RW (withdrawal request) | HeartSciences Inc. | 0001213900-24-110602 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-13 | S-1/A | registration statement | $4.50–$5.50 | 1,750,000 | - | Nasdaq HSCS | 1 | primary document; range, shares headline, cover names 1 | document ↗ | |
| 2022-06-17 | 424B4 | final prospectus | $4.25 | 1,500,000 | $6,375,000 | Nasdaq HSCS | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| HILZ MARK T | Director,Officer; Officer | COO, Secretary and Director; See Remarks | 6 | 2022–2025 | |
| Kanouff Patrick | Director | 1 | 2022 | ||
| Simpson Andrew | Director,Officer | See Remarks | 7 | 2022–2026 | |
| Szymczak Brian | Director | 5 | 2022–2025 | ||
| Watson Danielle | Officer | See Remarks | 6 | 2022–2026 | |
| Bent Bruce | Director | 5 | 2022–2026 | ||
| Wells David R. | Director | 5 | 2023–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-12-07 | Heart Test Laboratories, Inc. | Other Health Care | $934,997 | $934,997 | 1 | 1 |
| 2023-12-04 | Heart Test Laboratories, Inc. | Other Health Care | $1,085,006 | $1,085,006 | 2 | 2 |
| 2023-09-20 | Heart Test Laboratories, Inc. | Other Health Care | $1,000,000 | $1,000,000 | 1 | 1 |
| 2021-12-28 | Heart Test Laboratories, Inc. | Other Health Care | $4,400,000 | $2,000,000 | 18 | 1 |
| 2021-10-15 | Heart Test Laboratories, Inc. | Other Health Care | Indefinite | $640,000 | 14 | 1 |
| 2021-02-19 | Heart Test Laboratories, Inc. | Other Health Care | $1,500,000 | $1,100,000 | 40 | 1 |
| 2019-12-11 | Heart Test Laboratories, Inc. | Biotechnology | $4,000,000 | $3,897,504 | 44 | 1 |
| 2019-12-11 | Heart Test Laboratories, Inc. | Biotechnology | $6,500,000 | $6,493,155 | 50 | 1 |
| 2019-12-11 | Heart Test Laboratories, Inc. | Biotechnology | $4,500,000 | $138,000 | 8 | 1 |
| 2016-11-07 | Heart Test Laboratories, Inc. | Other Health Care | $7,000,000 | $0 | 0 | 1 |
| 2015-09-18 | Heart Test Laboratories, Inc. | Other Health Care | $5,000,000 | $0 | 32 | 1 |
| 2015-07-17 | Heart Test Laboratories, Inc. | Other Health Care | $10,000,000 | $4,211,000 | 32 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | HEARTSCIENCES INC. | TX | State business registries | name and state |
| Plan sponsor | HEARTSCIENCES INC. | TX | Form 5500 (employee benefit plans) | name and state |
| Form D issuer | Heart Test Laboratories, Inc. | TX | Form D private offerings | CIK (EXACT) |
| Patent assignee | HEARTSCIENCES INC. | TX | Patents (USPTO) | name and state |
| SEC filer | HeartSciences Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | HEARTSCIENCES INC. | TX | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | HEARTSCIENCES INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Finance Services, TX first:
- AVANTAX, INC. TX
- TRIAD FINANCIAL SM LLC TX
- Highland Financial Partners, L.P. TX
- Financial Gravity Companies, Inc. TX
- NetSpend Holdings, Inc. TX
- Elevate Credit, Inc. TX
- HYPERION DEFI, INC. TX
- Cango Inc. TX
- Beneficient TX
- ZeroStack Corp. TX
In other datasets, the same topic (Finance) in TX:
- Lobbying client: 7 ELEVEN, INC. (Federal lobbying (LDA))
Interests: Finance Services · Finance